WARFARIN ELIMINATION AND RESPONSIVENESS IN PATIENTS WITH RENAL DYSFUNCTION

被引：22

作者：

BACHMANN, K

SHAPIRO, R

MACKIEWICZ, J

机构：

[1] UNIV TOLEDO,COLL PHARM,TOLEDO,OH 43606

[2] MED COLL OHIO,TOLEDO,OH 43614

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1977年 / 17卷 / 5-6期

关键词：

D O I：

10.1002/j.1552-4604.1977.tb04608.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：292 / 299

页数：8

共 43 条

[1]

Aggeler P M, 1966, Thromb Diath Haemorrh Suppl, V21, P227

[2]

ANDERSON KE, 1976, CLIN PHARMACOL THER, V19, P47

[3]

ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059

[4]

BACHMANN K, 1976, J CLIN PHARMACOL, V16, P468

[5]

BAGDADE J, 1973, ANN NEW YORK ACAD SC, V226, P247

[6] TOBRAMYCIN IN RENAL IMPAIRMENT [J].

BECHTOL, LD ;

BLACK, HR .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 269 (03) :317-321

[7] GUIDE TO DRUG-THERAPY IN RENAL-FAILURE [J].

BENNETT, WM ;

SINGER, I ;

COGGINS, CJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (11) :1544-1553

[8]

BRECKENRIDGE A, 1973, CLIN PHARMACOL THERA, V14, P995

[9]

BRECKENRIDGE A, 1973, BIOL EFFECTS DRUGS R, P145

[10] GENTAMICIN THERAPY IN RENAL-FAILURE - NOMOGRAM FOR DOSAGE [J].

CHAN, RA ;

BENNER, EJ ;

HOEPRICH, PD .

ANNALS OF INTERNAL MEDICINE, 1972, 76 (05) :773-+

← 1 2 3 4 5 →